Interventionelle Therapie der Lungenembolie – aktueller Stand

Was ist neu?

Evidenz der systemischen Lysetherapie als Standardverfahren zur Rekanalisation Die Evidenz der systemischen Lysetherapie in High- und Intermediate-High-Lungenembolien ist niedrig. Ohne rekanalisierende Maßnahmen führt die Rechtsherz-Dekompensation in High- und Intermediate-High-Risk-Lungenembolien oft zum Tod.

Kathetergestützte Techniken In den letzten Jahren wurden mehrere Systeme zur interventionellen Rekanalisation bei Lungenembolie etabliert. Wie in anderen Feldern der vaskulären Medizin sind interventionelle Rekanalisationsmethoden auch bei der Lungenembolie potenziell effektiver als die systemische Lysetherapie, unter Umgehung erhöhter Blutungsrisiken. Auch wenn bisher Ergebnisse laufender randomisierter kontrollierter Endpunktstudien noch ausstehen, sind die bisherigen Daten vielversprechend.

Die Rolle des PERT-Teams Die zunehmend komplexere Behandlung der Lungenembolie erfordert spezialisierte interdisziplinäre Behandlungsteams, sog. Pulmonary-Artery-Response-Teams (PERT-Teams) und strukturierte Behandlungsabläufe.

Abstract

Several catheter-based systems have been developed for interventional recanalization of pulmonary embolism. These include local ultrasound assisted thrombolysis (EKOS), in-toto-thrombectomy via retriever and aspiration system (FlowTriever) and the Indigo mechanical aspiration system. Safety and efficacy in the removal of thrombus have been demonstrated for all systems. Interventional recanalization strategies for high- and intermediate-high risk pulmonary embolism are potentially more effective in the removal of thrombus and restoration of right heart function than systemic thrombolysis with a lower risk of major bleeding complications. Preliminary data from registries and observational studies are very promising whereas the evidence for systemic thrombolysis treatment in high and intermediate-high risk pulmonary embolism is low. Randomized controlled clinical trials are currently performed comparing catheter based interventional therapies to systemic thrombolysis for the treatment of intermediate-high risk pulmonary embolisms. Primary outcome measurements include mortality, hemodynamic collapse, and major bleedings. Results are expected in 2025. The introduction of interventional therapies for pulmonary embolism was accompanied by an increased awareness of the complexity of pulmonary embolism management. The need for specialized interdisciplinary pulmonary embolism response teams (PERT-teams) and a well-structured approach including a PDCA cycle was recognized.

Schlüsselwörter

Lungenarterienembolie - Rekanalisation - interventionell - Thrombolyse - PERT-Team - Qualitätsmanagement

Keywords

pulmonary embolism - recanalization - interventional - thrombolysis - PERT-Team - quality management

Publication History

Article published online:
23 May 2024

• Literatur

• 1 Cohen AT, Agnelli G, Anderson FA. et al. VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (04) 756-764
• 2 Konstantinides SV, Meyer G, Becattini C. et al. The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54 (03) 1901647
• 3 Linnemann B, Blank W, Doenst T. et al. Diagnostics and Therapy of Venous Thrombosis and Pulmonary Embolism. The revised AWMF S2k Guideline. Vasa 2023; 52 (Suppl. 111) 1-146
• 4 Zuo Z, Yue J, Dong BR. et al. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev 2021; 4 (04) CD004437
• 5 Marti C, John G, Konstantinides S. et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015; 36 (10) 605-614
• 6 Meyer G, Vicaut E, Danays T. et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370 (15) 1402-1411
• 7 Kucher N, Boekstegers P, Müller OJ. et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129 (04) 479-486
• 8 Toma C, Bunte MC, Cho KH. et al. Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry. Catheter Cardiovasc Interv 2022; 99 (04) 1345-1355
• 9 Planer D, Yanko S, Matok I. et al. Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis. CMAJ 2023; 195 (24) E833-E843
• 10 Mansella G, Keil C, Nickel CH. et al. Delayed Diagnosis in Pulmonary Embolism: Frequency, Patient Characteristics, and Outcome. Respiration 2020; 99 (07) 589-597
• 11 Scholz KH, Lengenfelder B, Jacobshagen C. et al. Long-term effects of a standardized feedback-driven quality improvement program for timely reperfusion therapy in regional STEMI care networks. Eur Heart J Acute Cardiovasc Care 2020;
• 12 Sagoschen I, Scibior B, Farmakis IT et. Al. A multidisciplinary pulmonary embolism response team (PERT): first experience from a single center in Germany. Clin Res Cardiol 2024; 113 (04) 581-590
• 13 Karwinski B, Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol 1989; 42 (02) 135-139
• 14 Saqqur M, Uchino K, Demchuk AM. et al. CLOTBUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38 (03) 948-954
• 15 Silver MJ, Gibson CM, Giri J. et al. Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study. Circ Cardiovasc Interv 2023; 16 (10) e013406